The National User Resource for Biological Accelerator Mass Spectrometry is supported by the National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) under grant number R24GM137748.
Once a project is incorporated into the User Facility, it will undergo annual review by the User Facility staff to ensure that adequate service is being provided and that adequate progress has been accomplished.
It is the project principal investigator’s responsibility to appropriately acknowledge all data provided by the User Facility as well as to provide information for our annual report to NIH. The appropriate acknowledgement is:
Work was performed in part at the National User Resource for Biological Accelerator Mass Spectrometry (AMS), which is operated at LLNL under the auspices of the U.S. Department of Energy under contract DE-AC52-07NA27344. The User Resource is supported by the National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) under grant R24GM137748.
User Facility acknowledgement (.docx) User Facility acknowledgement (.txt)
The User Facility Administrative Contact, Nanette Sorensen, will annually request updated information about each project. This information includes the personnel working on the project, the current source of financial support for the project, a statement describing progress and the ongoing work plan, AMS facility usage, and copies of resulting publications: journal articles, abstracts, and book chapters, whether published or in press. For reporting purposes, NIH requires that all publications be deposited in Pubmed Central. If deposition is not done by the journal, the primary or corresponding author should deposit the papers. If needed, contact the User Facility Project Manager, Bruce Buchholz, for assistance.
The National User Resource for Biological Accelerator Mass Spectrometry is supported by the National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) under grant number R24GM137748.